Implementation of the CAP/IASLC/AMP 2018 NSCLC Molecular Testing Guidelines

CAP/IASLC/AMP 2018 Molecular Testing Guidelines: NGS Test Phase ConsiderationsПодробнее

CAP/IASLC/AMP 2018 Molecular Testing Guidelines: Comprehensive Next Generation Sequencing (NGS)Подробнее

CAP/IASLC/AMP 2018 Molecular Testing Guidelines: NSCLC Biomarker Testing PlatformsПодробнее

CAP IASLC AMP Guideline OverviewПодробнее

CAP IASLC AMP Guideline OverviewПодробнее

Molecular Testing Guideline for CliniciansПодробнее

2018 Lung Cancer Update for Patients by the CAP-IASLC-AMPПодробнее

CAP/IASLC/AMP 2018 Molecular Testing Guidelines: Genomic Profiling and Biomarker TestingПодробнее

CAP/IASLC/AMP 2018 NSCLC Molecular Testing Guidelines: NSCLC Testing GuidelinesПодробнее

CAP IASLC AMP - The Pathologist's PerspectiveПодробнее

IASLC Webinar: Cancer Drug Development in the Era of Precision MedicineПодробнее

CAP IASLC AMP PATIENTПодробнее

The paradigm of lung cancer from therapy selection to resistance monitoringПодробнее

CAP IASLC AMP PATIENTПодробнее

ILCN Multidisciplinary Forum: The Role of Liquid Biopsy in NSCLCПодробнее

Molecular Testing for NSCLCПодробнее

CAP IASLC AMP Doc FocusПодробнее

LIS and EHR Implementation and Protocol Optimization for NSCLC Biomarker TestingПодробнее

NSCLC Workflows: TAT Considerations & GuidelinesПодробнее